Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China

BACKGROUND: To determine the efficacy of low-dose, immediate-release tacrolimus in patients with myasthenia gravis (MG) with inadequate response to glucocorticoid therapy in a randomized, double-blind, placebo-controlled study. METHODS: Eligible patients had inadequate response to glucocorticoids (G...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Lei, Liu, Weibin, Li, Wei, Li, Haifeng, Zhang, Xu, Shang, Huifang, Bu, Bitao, Deng, Hui, Fang, Qi, Li, Jimei, Zhang, Hua, Song, Zhi, Ou, Changyi, Yan, Chuanzhu, Liu, Tao, Zhou, Hongyu, Bao, Jianhong, Lu, Jiahong, Shi, Huawei, Zhao, Chongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557184/
https://www.ncbi.nlm.nih.gov/pubmed/28861121
http://dx.doi.org/10.1177/1756285617721092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557184/
https://www.ncbi.nlm.nih.gov/pubmed/28861121
http://dx.doi.org/10.1177/1756285617721092

Ejemplares similares